Literature DB >> 4120194

Lymphocyte actinomycin binding capacity in chronic lymphocytic leukaemia.

P Masera, A Pileri, J Brachet, N Hulin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4120194     DOI： 10.1007/bf01957868

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


× No keyword cloud information.
  5 in total

1.  A Simple Model for the Origin of Enantioselection and the Anti "Lock-and-Key" Motif in Asymmetric Hydrogenation of Enamides as Catalyzed by Chiral Diphosphine Complexes of Rh(I) This work was supported by the National Science Foundation (CHE-9618497) and by the National Center for Supercomputer Applications under MCA99S017N and used the CRAY ORIGIN 2000 computer system at the NCSA.

Authors: 
Journal:  Angew Chem Int Ed Engl       Date:  2000-08-18       Impact factor: 15.336

2.  Identification of human T and B lymphocytes in normal peripheral blood and in chronic lymphocytic leukaemia.

Authors:  J D Wilson; G J Nossal
Journal:  Lancet       Date:  1971-10-09       Impact factor: 79.321

3.  Binding of tritiated actinomycin and cell differentiation.

Authors:  J Brachet; N Hulin
Journal:  Nature       Date:  1969-05-03       Impact factor: 49.962

4.  Actinomycin binding of normal and phytohaemagglutinin stimulated lymphocytes.

Authors:  Z Darzynkiewicz; L Bolund; N R Ringertz
Journal:  Exp Cell Res       Date:  1969-04       Impact factor: 3.905

5.  Immunoglobulins as cell receptors.

Authors:  B Pernis; L Forni; L Amante
Journal:  Ann N Y Acad Sci       Date:  1971-12-31       Impact factor: 5.691
  5 in total
  2 in total

Review 1.  [Molecular biology of the lymphocyte of the chronic lymphocytic leukemia (author's transl)].

Authors:  S Seeber; C G Schmidt
Journal:  Klin Wochenschr       Date:  1974-12-01

2.  Comparative studies on phenol-soluble nonhistone chromatin proteins in normal and leukaemic human leukocytes.

Authors:  S Seeber; T Meshkov; K P Brucksch; J Käding; C G Schmidt; H Busch
Journal:  Klin Wochenschr       Date:  1979-03-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.